Texas
ABA / Autism Therapy for Sale — Texas
- Asking price
- $2,500,000
- Annual revenue
- $2,400,000
- Type
- ABA / Autism Therapy
- Location
- Texas
- Listing verified
- 2026-10-09
Listing broker
This mental health practice is represented by American HealthCare Capital (PRIME exits). Full identity and financials come directly from the listing broker, typically after a confidentiality agreement.
View this listing on the broker's siteMore mental health practices for sale in Texas
Behavioral Health Practice
Texas
PRIME exits and American Healthcare Capital are pleased to introduce the largest provider of medical services for private-sector behavioral healthcare hospitals in Texas. The company’s team of family practice doctors, physician assistants, and nurse practitioners provide state-mandated history and physical assessments and medical follow-up care for 100% of patients in several behavioral health hospitals located in major metropolitan areas of Texas.The company treats patients from a wide range of cultural and socioeconomic backgrounds and their practice is committed to providing the highest level of services to patients struggling with or in recovery from addiction or other psychiatric disorders. The practice has earned nationwide recognition in the medical and mental health treatment fields.The practice is centrally managed from a single office, and all employees perform their job functions remotely. The company is also highly efficient in billing and collections and has existing insurance contracts with all major providers in the state of Texas, both in managed Medicare/Medicaid and private insurance. The practice averages 8,500 patient events per month. All referrals come through patients admitted to contracted hospitals.
- Asking price
- $20,000,000
- Annual revenue
- $7,800,000
Listed by American HealthCare Capital (PRIME exits)
Behavioral Health Practice
Texas
In 2022, total gross revenue was $3,731,498 with an adjusted EBITDA of $1,359, 847. In 2023, the company’s gross revenue was $4,424,056 with an adjusted EBITDA of $1,281,057. The company is on track to reach $6 million in gross revenue in 2024 with an adjusted EBITDA of $1,955,373. They are currently in talks with a major hospital to secure a contract that is expected to increase EBITDA by 15 – 20%. Beyond this, there are ample opportunities for additional growth, both within their existing customer base, additional vertical markets via telemedicine, and through expansion to new geographies.
- Annual revenue
- $6,000,000
Listed by American HealthCare Capital (PRIME exits)
Substance Use Treatment
Texas
American HealthCare Capital is pleased to introduce an Addiction Treatment Center located in a premier Texas location. Based in one of the fastest-growing markets in the US, the company is well-connected to the largest residential treatment providers. They serve patients based all over the United States due to their clinical expertise in treating process addictions. The center was recently licensed and accredited, and they are at the forefront and cutting edge of the industry. The business continues to see monthly increases, and the company has booked new insurance contracts with some of the largest providers. They are currently having a very strong year and experiencing their best growth yet due to an increased volume of telehealth clients and an uptick in demand for mental health services. Based on results through October, in 2020 they are projected to gross at least $1.9 million with an adjusted EBITDA of $730,000. The asking price for this opportunity is $3 million.
- Asking price
- $3,000,000
- Annual revenue
- $1,900,000
Listed by American HealthCare Capital (PRIME exits)